Figure 1
PRISMA flow diagram.
Figure 2
Average cost-effectiveness of treating cholesterol per DALY averted relative to GDP per capita. Note: The overlapping circles (i.e., with similar or very close ACER values) are presented as jittered around the respective values for better visualization of the number of interventions assessed. See Supplementary Table 4 for study- and intervention-specific ACERs, treatment description, and intervention sub-groups.
Figure 3
Incremental cost-effectiveness of treating cholesterol per DALY averted relative to GDP per capita Note: The overlapping circles (i.e., with similar or very close ACER values) are presented as jittered around the respective values for better visualization of the number of interventions assessed. See Supplementary Table 4 for study- and intervention-specific ICERs.
Figure 4
Average cost-effectiveness of treating cholesterol per QALY gained and relative to 1x GDP per capita, 2019 USD Note: The overlapping circles (i.e., with similar or very close ACER values) are presented as jittered around the respective values for better visualization of the number of interventions assessed. See Supplementary Table 5 for study- and intervention-specific ACERs.
Figure 5
Average cost-effectiveness ratio (ACER) of treating cholesterol, 2019 USD.